Online inquiry

IVTScrip™ mRNA-Human AKAP5, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK17762MR)

This product GTTS-WK17762MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AKAP5 protein. This product can be used in Exhausted CD8+ T cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_004857.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 9495
UniProt ID P24588
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AKAP5, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK17762MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK17765MR IVTScrip™ mRNA-Human AKAP8L, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AKAP8L
GTTS-WK12909MR IVTScrip™ mRNA-Human A2ML1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA A2ML1
GTTS-WK17766MR IVTScrip™ mRNA-Human AKAP9, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AKAP9
GTTS-WK7165MR IVTScrip™ mRNA-Human CD142, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA CD142
GTTS-WK2292MR IVTScrip™ mRNA-Human NRP1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA NRP1
GTTS-WK15057MR IVTScrip™ mRNA-Human AKAP12, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AKAP12
GTTS-WK6236MR IVTScrip™ mRNA-Human EFNA2, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA EFNA2
GTTS-WK21832MR IVTScrip™ mRNA-Human ASXL2, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ASXL2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →